Clinical Trials Browser

Phase 2 × pazopanib × Gynecologic × Clear all

Ovarian Neoplasms

NCT01610206 2021-02-25

A Randomized Study of Safety and Efficacy of Pazopanib and Gemcitabine in Persistent or Relapsed Ovarian Cancer

Phase 2 Completed

148 enrolled 11 charts

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Recurrence

NCT01392352 2020-02-13

HYPAZ

Phase 2 Terminated

31 enrolled

BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Gastrointestinal Neoplasms, Glioblastoma, Hypertension, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Sarcoma, Small Cell Lung Carcinoma

NCT01247571 2019-08-08

Pazopanib Hydrochloride in Treating Patients With Recurrent or Persistent Uterine Cancer

Phase 2 Completed

22 enrolled 8 charts

GynecologicSarcoma

Recurrent Uterine Corpus Sarcoma

NCT01468909 2019-07-23

Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Persistent or Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer

Phase 2 Completed

106 enrolled 13 charts

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00281632 2018-09-17

A Phase II, Open-Label Study Evaluating the Effect Of GW786034 In Subjects With Ovarian Cancer

Phase 2 Completed

35 enrolled 24 charts

Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT01644825 2018-04-09

MITO-11

Phase 2 Completed

72 enrolled

Gynecologic

Ovarian Neoplasms

NCT02348398 2016-08-16

Phase II Study of Pazopanib and Topotecan in Cervical Cancer

Phase 2 Withdrawn

Gynecologic

Uterine Cervical Neoplasms

NCT00430781 2015-05-08

Pazopanib Plus Lapatinib Compared to Lapatinib Alone and Pazopanib Alone In Subjects With Metastatic Cervical Cancer

Phase 2 Completed

228 enrolled 21 charts

Gynecologic

Uterine Cervical Neoplasms, Neoplasms, Recurrence

NCT01227928 2015-03-03

Efficacy and Safety of Pazopanib Monotherapy After First-line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Asian Women

Phase 2 Completed

145 enrolled 19 charts

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00561795 2012-03-22

Feasibility Study of Pazopanib in Combination With Chemotherapy in Gynaecological Tumors

Phase 2 Completed

12 enrolled 6 charts

Gynecologic

Carcinoma, Ovarian Epithelial, Uterine Cervical Diseases, Neoplasms, Ovarian Neoplasms, Uterine Diseases

Clinical Trials

TAPAZ

A Randomized Study of Safety and Efficacy of Pazopanib and Gemcitabine in Persistent or Relapsed Ovarian Cancer

HYPAZ

Pazopanib Hydrochloride in Treating Patients With Recurrent or Persistent Uterine Cancer

Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Persistent or Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer

A Phase II, Open-Label Study Evaluating the Effect Of GW786034 In Subjects With Ovarian Cancer

MITO-11

Phase II Study of Pazopanib and Topotecan in Cervical Cancer

Pazopanib Plus Lapatinib Compared to Lapatinib Alone and Pazopanib Alone In Subjects With Metastatic Cervical Cancer

Efficacy and Safety of Pazopanib Monotherapy After First-line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Asian Women

Feasibility Study of Pazopanib in Combination With Chemotherapy in Gynaecological Tumors